Sort
82,697 grants matching “vaccine development”
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
$2,185,000Robert Zygmunt Orlowski · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
SPORE: Brain Tumore SPORE Grant
$2,185,000Mitchel S. Berger · University Of California, San Francisco · P50 · FY2015 · CA
Pacific Ovarian Cancer Research Consortium
$2,185,000Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2011 · CA
Seattle Cancer Consortium Breast SPORE
$2,185,000Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2011 · CA
SPORE in Skin Cancer
$2,185,000John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
Mayo Clinic SPORE in Pancreatic Cancer
$2,185,000Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2011 · CA
SPORE in Lymphoma
$2,184,999Helen E Heslop · Baylor College Of Medicine · P50 · FY2015 · CA
Mayo Clinic Ovarian Cancer SPORE
$2,184,999Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2015 · CA
The Gonorrhea Vaccine Cooperative Research Center
$2,184,973Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Washington University SPORE in Pancreatic Cancer
$2,184,707William G Hawkins · Washington University · P50 · FY2020 · CA
The UCSD CD4 Collaborative Clinical Trial Unit
$2,184,106Constance Ann Benson · University Of California, San Diego · UM1 · FY2018 · AI
Genetic Approaches To Understanding Organ Development and Function
$2,183,970Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
$2,183,683Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2015 · CA
EMORY/ATLANTA CENTER FOR AIDS RESEARCH(CFAR)
$2,183,568Emory University · P30 · FY2005 · AI
SPORE in Breast Cancer
$2,182,992Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2006 · CA
Small molecule stimulators for use as adjuvants for antiviral vaccines
$2,181,933Michael J Gale · University Of Washington · N01 · FY2010 · AI
Cellular and Molecular Defects in Human B Cell Development
$2,181,897Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2017 · AI
DEVELOPMENT OF A LASSA FEVER VIRUS VACCINE
$2,181,107Peter Pushko · Medigen, Inc. · N01 · FY2025 · AI
Immuno-Prophylaxis-Therapy & Diagnosis of Tularemia
$2,180,538John R. Murphy · Boston Medical Center · U19 · FY2006 · AI
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
$2,180,520Matthew Adrian Coleman · University Of Calif-Lawrnc Lvrmr Nat Lab · U19 · FY2019 · AI
Integrative analysis and modeling of human immune responses and pathologies
$2,180,475John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Optimizing HIV immunogen-BCR interactions for vaccine development
$2,180,408Leonidas A Stamatatos · Seattle Biomedical Research Institute · P01 · FY2012 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$2,180,144Chuck Squires · Pfenex, Inc. · N01 · FY2012 · AI
SPORE in Gastrointestinal Cancer
$2,179,684Alison P Klein · Johns Hopkins University · P50 · FY2015 · CA
SPORE in Prostate Cancer
$2,179,681Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2010 · CA